208 related articles for article (PubMed ID: 33900108)
21. Evidence for 1,25-dihydroxyvitamin D3-independent transactivation by the vitamin D receptor: uncoupling the receptor and ligand in keratinocytes.
Ellison TI; Eckert RL; MacDonald PN
J Biol Chem; 2007 Apr; 282(15):10953-62. PubMed ID: 17310066
[TBL] [Abstract][Full Text] [Related]
22. Synthesis, metabolism, and biological activity of 2-[3-(tetrazolyl)propyl]-1α,25-dihydroxy-19-norvitamin D
Takano M; Yasuda K; Higuchi E; Tohyama E; Takeuchi A; Sakaki T; Kittaka A
J Steroid Biochem Mol Biol; 2016 Nov; 164():40-44. PubMed ID: 26232635
[TBL] [Abstract][Full Text] [Related]
23. Regulation of the human cyclin C gene via multiple vitamin D3-responsive regions in its promoter.
Sinkkonen L; Malinen M; Saavalainen K; Väisänen S; Carlberg C
Nucleic Acids Res; 2005; 33(8):2440-51. PubMed ID: 15863722
[TBL] [Abstract][Full Text] [Related]
24. Co-expression of 1α-hydroxylase and vitamin D receptor in human articular chondrocytes.
Hansen AK; Figenschau Y; Zubiaurre-Martinez I
BMC Musculoskelet Disord; 2017 Nov; 18(1):432. PubMed ID: 29110708
[TBL] [Abstract][Full Text] [Related]
25. A chromatin-based mechanism controls differential regulation of the cytochrome P450 gene
Meyer MB; Lee SM; Carlson AH; Benkusky NA; Kaufmann M; Jones G; Pike JW
J Biol Chem; 2019 Sep; 294(39):14467-14481. PubMed ID: 31439663
[TBL] [Abstract][Full Text] [Related]
26. The Wnt antagonist DICKKOPF-1 gene is induced by 1alpha,25-dihydroxyvitamin D3 associated to the differentiation of human colon cancer cells.
Aguilera O; Peña C; García JM; Larriba MJ; Ordóñez-Morán P; Navarro D; Barbáchano A; López de Silanes I; Ballestar E; Fraga MF; Esteller M; Gamallo C; Bonilla F; González-Sancho JM; Muñoz A
Carcinogenesis; 2007 Sep; 28(9):1877-84. PubMed ID: 17449905
[TBL] [Abstract][Full Text] [Related]
27. Cross-talk of Aryl Hydrocarbon Receptor (AHR)- and Vitamin D Receptor (VDR)-signaling in Human Keratinocytes.
Christofi C; Lamnis L; Stark A; Palm H; Römer K; Vogt T; Reichrath J
Anticancer Res; 2022 Oct; 42(10):5049-5067. PubMed ID: 36191995
[TBL] [Abstract][Full Text] [Related]
28. VDR primary targets by genome-wide transcriptional profiling.
Goeman F; De Nicola F; D'Onorio De Meo P; Pallocca M; Elmi B; Castrignanò T; Pesole G; Strano S; Blandino G; Fanciulli M; Muti P
J Steroid Biochem Mol Biol; 2014 Sep; 143():348-56. PubMed ID: 24726990
[TBL] [Abstract][Full Text] [Related]
29. Selection of High-Quality Spermatozoa May Be Promoted by Activated Vitamin D in the Woman.
Bøllehuus Hansen L; Rehfeld A; de Neergaard R; Nielsen JE; Iversen LH; Boisen IM; Mortensen LJ; Lanske B; Almstrup K; Carlsen E; Berg AH; Jørgensen N; Andersen AN; Juul A; Blomberg Jensen M
J Clin Endocrinol Metab; 2017 Mar; 102(3):950-961. PubMed ID: 27977320
[TBL] [Abstract][Full Text] [Related]
30. Singly dehydroxylated A-ring analogues of 19-nor-1alpha,25-dihydroxyvitamin D3 and 19-nor-22-oxa-1alpha,25-dihydroxyvitamin D3: novel vitamin D3 analogues with potent transcriptional activity but extremely low affinity for vitamin D receptor.
Okano T; Nakagawa K; Tsugawa N; Ozono K; Kubodera N; Osawa A; Terada M; Mikami K
Biol Pharm Bull; 1998 Dec; 21(12):1300-5. PubMed ID: 9881643
[TBL] [Abstract][Full Text] [Related]
31. A High-Calcium and Phosphate Rescue Diet and VDR-Expressing Transgenes Normalize Serum Vitamin D Metabolite Profiles and Renal Cyp27b1 and Cyp24a1 Expression in VDR Null Mice.
Kaufmann M; Lee SM; Pike JW; Jones G
Endocrinology; 2015 Dec; 156(12):4388-97. PubMed ID: 26441239
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and metabolic studies of 1α,2α,25-, 1α,4α,25- and 1α,4β,25-trihydroxyvitamin D3.
Takano M; Sawada D; Yasuda K; Nishikawa M; Takeuchi A; Takagi K; Horie K; Reddy GS; Chen TC; Sakaki T; Kittaka A
J Steroid Biochem Mol Biol; 2015 Apr; 148():34-7. PubMed ID: 25263656
[TBL] [Abstract][Full Text] [Related]
33. Vitamin D receptor expression and associated gene signature in tumour stromal fibroblasts predict clinical outcome in colorectal cancer.
Ferrer-Mayorga G; Gómez-López G; Barbáchano A; Fernández-Barral A; Peña C; Pisano DG; Cantero R; Rojo F; Muñoz A; Larriba MJ
Gut; 2017 Aug; 66(8):1449-1462. PubMed ID: 27053631
[TBL] [Abstract][Full Text] [Related]
34. 1α,25(OH)2D3 differentially regulates miRNA expression in human bladder cancer cells.
Ma Y; Hu Q; Luo W; Pratt RN; Glenn ST; Liu S; Trump DL; Johnson CS
J Steroid Biochem Mol Biol; 2015 Apr; 148():166-71. PubMed ID: 25263658
[TBL] [Abstract][Full Text] [Related]
35. Constitutively active RAS signaling reduces 1,25 dihydroxyvitamin D-mediated gene transcription in intestinal epithelial cells by reducing vitamin D receptor expression.
DeSmet ML; Fleet JC
J Steroid Biochem Mol Biol; 2017 Oct; 173():194-201. PubMed ID: 28104492
[TBL] [Abstract][Full Text] [Related]
36. Chromatin acetylation at transcription start sites and vitamin D receptor binding regions relates to effects of 1α,25-dihydroxyvitamin D3 and histone deacetylase inhibitors on gene expression.
Seuter S; Heikkinen S; Carlberg C
Nucleic Acids Res; 2013 Jan; 41(1):110-24. PubMed ID: 23093607
[TBL] [Abstract][Full Text] [Related]
37. The vitamin D receptor in the proximal renal tubule is a key regulator of serum 1α,25-dihydroxyvitamin D₃.
Wang Y; Zhu J; DeLuca HF
Am J Physiol Endocrinol Metab; 2015 Feb; 308(3):E201-5. PubMed ID: 25425001
[TBL] [Abstract][Full Text] [Related]
38. The anti-proliferative effects of 1alpha,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression.
Campbell MJ; Gombart AF; Kwok SH; Park S; Koeffler HP
Oncogene; 2000 Oct; 19(44):5091-7. PubMed ID: 11042697
[TBL] [Abstract][Full Text] [Related]
39. 1α,25-Dihydroxyvitamin D
Ishizawa M; Akagi D; Yamamoto J; Makishima M
J Steroid Biochem Mol Biol; 2017 Sep; 172():55-61. PubMed ID: 28578001
[TBL] [Abstract][Full Text] [Related]
40. Vitamin D-dependent chromatin association of CTCF in human monocytes.
Neme A; Seuter S; Carlberg C
Biochim Biophys Acta; 2016 Nov; 1859(11):1380-1388. PubMed ID: 27569350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
